
    
      This study is to evaluate the efficacy and safety of ASP1941 in combination with sulfonylurea
      in subjects with type 2 diabetes mellitus (T2DM) who have inadequate glycemic control with
      sulfonylurea alone. The effects of ASP1941 are compared with those of placebo. Double blind
      period continues for 24 weeks followed by open period in each patient.
    
  